InsiderTrades.com logo

NBY Insider Trading

Insider Ownership Percentage: 20.10%
Insider Buying (Last 12 Months): $188,977.78
Insider Selling (Last 12 Months): $0.00

NovaBay Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at NovaBay Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

NovaBay Pharmaceuticals Share Price & Price History

Current Price: $1.09
Price Change: ▲ Price Increase of +0.03 (2.83%)
As of 12/4/2025 05:10 PM ET

This chart shows the closing price history over time for NBY up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

NovaBay Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/8/2025Poplar Point Capital PartnersMajor ShareholderBuy300$0.47$141.001,020,300View SEC Filing Icon  
4/4/2025Poplar Point Capital PartnersMajor ShareholderBuy4,538$0.52$2,359.761,020,000View SEC Filing Icon  
4/2/2025Poplar Point Capital PartnersMajor ShareholderBuy917$0.58$531.86992,486View SEC Filing Icon  
3/31/2025Poplar Point Capital PartnersMajor ShareholderBuy21,654$0.59$12,775.86971,654View SEC Filing Icon  
3/28/2025Poplar Point Capital PartnersMajor ShareholderBuy49,400$0.61$30,134.00950,000View SEC Filing Icon  
3/26/2025Poplar Point Capital PartnersMajor ShareholderBuy13,292$0.61$8,108.12881,496View SEC Filing Icon  
3/24/2025Poplar Point Capital PartnersMajor ShareholderBuy100$0.60$60.00845,569View SEC Filing Icon  
3/20/2025Poplar Point Capital PartnersMajor ShareholderBuy5,320$0.61$3,245.20839,097View SEC Filing Icon  
3/18/2025Poplar Point Capital PartnersMajor ShareholderBuy14,000$0.63$8,820.00832,277View SEC Filing Icon  
3/14/2025Poplar Point Capital PartnersMajor ShareholderBuy25,511$0.63$16,071.93808,277View SEC Filing Icon  
3/12/2025Poplar Point Capital PartnersMajor ShareholderBuy11,837$0.62$7,338.94782,732View SEC Filing Icon  
3/10/2025Poplar Point Capital PartnersMajor ShareholderBuy14,645$0.58$8,494.10768,747View SEC Filing Icon  
3/7/2025Poplar Point Capital PartnersMajor ShareholderBuy102$0.55$56.10754,102View SEC Filing Icon  
3/4/2025Poplar Point Capital PartnersMajor ShareholderBuy4,000$0.58$2,320.00754,000View SEC Filing Icon  
2/27/2025Poplar Point Capital PartnersMajor ShareholderBuy385$0.61$234.85736,892View SEC Filing Icon  
2/25/2025Poplar Point Capital PartnersMajor ShareholderBuy25,033$0.62$15,520.46730,205View SEC Filing Icon  
2/20/2025Poplar Point Capital PartnersMajor ShareholderBuy1,836$0.63$1,156.68704,722View SEC Filing Icon  
2/18/2025Poplar Point Capital PartnersMajor ShareholderBuy3,222$0.66$2,126.52653,222View SEC Filing Icon  
2/3/2025Poplar Point Capital PartnersMajor ShareholderBuy2,597$0.64$1,662.08623,282View SEC Filing Icon  
1/31/2025Poplar Point Capital PartnersMajor ShareholderBuy70,685$0.65$45,945.25620,685View SEC Filing Icon  
1/27/2025Poplar Point Capital PartnersMajor ShareholderBuy31,703$0.69$21,875.07550,000View SEC Filing Icon  
12/6/2022Audrey KuninInsiderSell1$1.81$1.81View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for NovaBay Pharmaceuticals (NYSEAMERICAN:NBY)

23.25% of NovaBay Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at NBY by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

NovaBay Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/6/2025Ground Swell Capital LLC19,158$25K0.1%N/A0.319%Search for SEC Filing on Google Icon
10/17/2025Apollon Wealth Management LLC27,561$35K0.0%N/A0.459%Search for SEC Filing on Google Icon
7/17/2025C2C Wealth Management LLC98,000$57K0.1%+78.2%1.685%Search for SEC Filing on Google Icon
2/13/2024Armistice Capital LLC718,768$0.15M0.0%N/A11.007%Search for SEC Filing on Google Icon
11/14/2022Altium Capital Management LP1,095,957$0.12M0.0%N/A1.686%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
NovaBay Pharmaceuticals logo
NovaBay Pharmaceuticals, Inc. develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health. The company also provides wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands. It sells its products through the company's web stores, third-party online retailers and distribution partners. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.
Read More on NovaBay Pharmaceuticals

Today's Range

Now: $1.09
Low: $1.01
High: $1.09

50 Day Range

MA: $1.18
Low: $0.86
High: $2.36

52 Week Range

Now: $1.09
Low: $0.46
High: $4.44

Volume

47,063 shs

Average Volume

115,941 shs

Market Capitalization

$137.35 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.57

Who are the company insiders with the largest holdings of NovaBay Pharmaceuticals?

NovaBay Pharmaceuticals' top insider investors include:
  1. Poplar Point Capital Partners (Major Shareholder)
Learn More about top insider investors at NovaBay Pharmaceuticals.

Who are the major institutional investors of NovaBay Pharmaceuticals?

NovaBay Pharmaceuticals' top institutional investors include:
  1. Apollon Wealth Management LLC — 0.46%
  2. Ground Swell Capital LLC — 0.32%
Learn More about top institutional investors of NovaBay Pharmaceuticals stock.

Which institutional investors are buying NovaBay Pharmaceuticals stock?

During the previous quarter, NBY stock was bought by institutional investors including:
  1. Apollon Wealth Management LLC
  2. Ground Swell Capital LLC